Genoray제노레이
122310 · KOSDAQ · ₩122310 · 제노레이
₩3,095▼ ₩10 (0.32%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩108B | ₩107B | ₩98B | ₩83B | ₩74B |
| Cost of sales | ₩66B | ₩67B | ₩60B | ₩47B | ₩43B |
| Gross profit | ₩42B | ₩40B | ₩38B | ₩35B | ₩31B |
| Operating income | −₩243M | ₩6.5B | ₩13B | ₩15B | ₩15B |
| Net income | ₩628M | −₩2.5B | ₩12B | ₩14B | ₩14B |
| Net income to shareholders | ₩758M | −₩1.8B | ₩12B | ₩14B | ₩14B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩131B | ₩123B | ₩124B | ₩106B | ₩99B |
| Current assets | ₩78B | ₩74B | ₩69B | ₩68B | ₩72B |
| Cash and equivalents | ₩14B | ₩16B | ₩5.2B | ₩5.1B | ₩20B |
| Total liabilities | ₩47B | ₩38B | ₩29B | ₩18B | ₩21B |
| Current liabilities | ₩40B | ₩30B | ₩23B | ₩17B | ₩19B |
| Borrowings | ₩23B | ₩19B | ₩12B | ₩9.2B | ₩11B |
| Total equity | ₩84B | ₩85B | ₩96B | ₩88B | ₩79B |
| Shareholders' equity | ₩84B | ₩86B | ₩95B | ₩88B | ₩79B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩5.3B | ₩13B | ₩3.6B | ₩15B | ₩15B |
| Capital spending | ₩1.3B | ₩4.2B | ₩2.9B | ₩9.2B | ₩5.3B |
| Free cash flow | ₩4B | ₩9.1B | ₩667M | ₩5.6B | ₩10B |
| Dividends paid | ₩2.2B | ₩2.2B | ₩2.2B | ₩2.4B | ₩1.7B |
Consolidated where available. Amounts in won.
Also known as: Genoray / 제노레이 / 122310 / KRX:122310
Source: KRX statistical information